Indications
Infanrix HepB is indicated for active immunisation of all infants from the age of 2 months againstdiphtheria, tetanus, pertussis and hepatitis B.
Composition
- Active substance
- Diphtheria toxoid, tetanus toxoid, pertussis toxoid, pertussis haemagglutin filamentous, pertactin, hepatitis B recombinant surface antigen
- International name (INN)
- diphtheria, tetanus, acellular pertussis and hepatitis B recombinant, adsorbed vaccine
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Infanrix HepB
- ATC code
- J07CA
- Therapeutic area
- Hepatitis B, Tetanus, Immunization, Whooping Cough, Diphtheria